BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY

Aim of the study Medication related osteonecrosis of the jaw (MRONJ) is a severe drug adverse effect, often being diagnosed in an advanced stage. The aim of this epidemiological study was to determine the frequency of MRONJ in cancer patients from Oltenia region, during 2012-2017. Material and metho...

Full description

Bibliographic Details
Main Authors: George Adrian Ciobanu, Adrian Camen, Mihaela Ionescu, Daniel Vlad, Veronica Mercuț, Ionela Elisabeta Staicu, Gabriel Sebastian Petrescu, Adel Aila Asan, Sanda Mihaela Popescu
Format: Article
Language:English
Published: Romanian Society of Oral Rehabilitation 2022-08-01
Series:Romanian Journal of Oral Rehabilitation
Subjects:
Online Access:https://www.rjor.ro/bisphosphonates-related-osteonecrosis-of-the-jaw-in-cancer-patients-epidemiological-study/
_version_ 1828004277535113216
author George Adrian Ciobanu
Adrian Camen
Mihaela Ionescu
Daniel Vlad
Veronica Mercuț
Ionela Elisabeta Staicu
Gabriel Sebastian Petrescu
Adel Aila Asan
Sanda Mihaela Popescu
author_facet George Adrian Ciobanu
Adrian Camen
Mihaela Ionescu
Daniel Vlad
Veronica Mercuț
Ionela Elisabeta Staicu
Gabriel Sebastian Petrescu
Adel Aila Asan
Sanda Mihaela Popescu
author_sort George Adrian Ciobanu
collection DOAJ
description Aim of the study Medication related osteonecrosis of the jaw (MRONJ) is a severe drug adverse effect, often being diagnosed in an advanced stage. The aim of this epidemiological study was to determine the frequency of MRONJ in cancer patients from Oltenia region, during 2012-2017. Material and methods Data retrieved from the clinical charts and used in this study were age, gender, residency, neoplasm type, location, and stage of MRONJ. Microsoft Excel and SPSS for Windows were used for analysis. Results The study included 57 patients, 31 females and 26 males, mean age 63.8±9.8. MRONJ was found in older patients, females mostly under 65 years old, males mostly over 65 years old (p = 0.023). Age distribution was correlated with the neoplasm type, while median ages between the breast neoplasm (58.5 years old) and prostate neoplasm (70 years old) groups were significantly different (p = 0.002). All patients with MRONJ have been previously treated with intravenous zoledronic acid for bone metastasis. Mandibular MRONJ was 2.35 times more frequent than maxillary MRONJ (p = 0.002) and stage II of MRONJ was commonly encountered. Conclusions MRONJ has been found mostly in patients with breast or prostate adenoma cancers with bone metastases who have been treated with intravenous. zoledronic acid and was present especially in the lower jaw, in advanced stages.
first_indexed 2024-04-10T07:12:27Z
format Article
id doaj.art-f2315f100f0d455a8f590b0b2241c100
institution Directory Open Access Journal
issn 2066-7000
2601-4661
language English
last_indexed 2024-04-10T07:12:27Z
publishDate 2022-08-01
publisher Romanian Society of Oral Rehabilitation
record_format Article
series Romanian Journal of Oral Rehabilitation
spelling doaj.art-f2315f100f0d455a8f590b0b2241c1002023-02-26T10:41:21ZengRomanian Society of Oral RehabilitationRomanian Journal of Oral Rehabilitation2066-70002601-46612022-08-011435666BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDYGeorge Adrian Ciobanu0Adrian Camen1Mihaela Ionescu2Daniel Vlad3Veronica Mercuț4Ionela Elisabeta Staicu5Gabriel Sebastian Petrescu6Adel Aila Asan7Sanda Mihaela Popescu8University of Medicine and Pharmacy of Craiova, Romania, Faculty of Dental Medicine, Department of Oral RehabilitationUniversity of Medicine and Pharmacy of Craiova, Romania, Faculty of Dental Medicine, Department of Oral and Maxillofacial SurgeryUniversity of Medicine and Pharmacy of Craiova, Romania, Faculty of Dental Medicine, Department of Medical Informatics and Biostatistics"Ovidius" University of Constanta, Romania, Dental Medicine Faculty, Department of Oral and Maxillofacial SurgeryUniversity of Medicine and Pharmacy of Craiova, Romania, Faculty of Dental Medicine, Department of ProsthodonticsUniversity of Medicine and Pharmacy of Craiova, Romania, Faculty of Dental Medicine, Department of OrthodonticsUniversity of Medicine and Pharmacy of Craiova, Romania, Faculty of Dental Medicine, Department of Oral and Maxillofacial SurgeryThe County Emergency Clinical Hospital “Sf. Apostol Andrei” Constanta, Department of Oral and Maxillofacial SurgeryUniversity of Medicine and Pharmacy of Craiova, Romania, Faculty of Dental Medicine, Department of Oral RehabilitationAim of the study Medication related osteonecrosis of the jaw (MRONJ) is a severe drug adverse effect, often being diagnosed in an advanced stage. The aim of this epidemiological study was to determine the frequency of MRONJ in cancer patients from Oltenia region, during 2012-2017. Material and methods Data retrieved from the clinical charts and used in this study were age, gender, residency, neoplasm type, location, and stage of MRONJ. Microsoft Excel and SPSS for Windows were used for analysis. Results The study included 57 patients, 31 females and 26 males, mean age 63.8±9.8. MRONJ was found in older patients, females mostly under 65 years old, males mostly over 65 years old (p = 0.023). Age distribution was correlated with the neoplasm type, while median ages between the breast neoplasm (58.5 years old) and prostate neoplasm (70 years old) groups were significantly different (p = 0.002). All patients with MRONJ have been previously treated with intravenous zoledronic acid for bone metastasis. Mandibular MRONJ was 2.35 times more frequent than maxillary MRONJ (p = 0.002) and stage II of MRONJ was commonly encountered. Conclusions MRONJ has been found mostly in patients with breast or prostate adenoma cancers with bone metastases who have been treated with intravenous. zoledronic acid and was present especially in the lower jaw, in advanced stages.https://www.rjor.ro/bisphosphonates-related-osteonecrosis-of-the-jaw-in-cancer-patients-epidemiological-study/bisphosphonate-associated osteonecrosis of the jawdiphosphonatesmandibleosteonecrosisneoplasms
spellingShingle George Adrian Ciobanu
Adrian Camen
Mihaela Ionescu
Daniel Vlad
Veronica Mercuț
Ionela Elisabeta Staicu
Gabriel Sebastian Petrescu
Adel Aila Asan
Sanda Mihaela Popescu
BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
Romanian Journal of Oral Rehabilitation
bisphosphonate-associated osteonecrosis of the jaw
diphosphonates
mandible
osteonecrosis
neoplasms
title BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
title_full BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
title_fullStr BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
title_full_unstemmed BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
title_short BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
title_sort bisphosphonates related osteonecrosis of the jaw in cancer patients epidemiological study
topic bisphosphonate-associated osteonecrosis of the jaw
diphosphonates
mandible
osteonecrosis
neoplasms
url https://www.rjor.ro/bisphosphonates-related-osteonecrosis-of-the-jaw-in-cancer-patients-epidemiological-study/
work_keys_str_mv AT georgeadrianciobanu bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy
AT adriancamen bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy
AT mihaelaionescu bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy
AT danielvlad bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy
AT veronicamercut bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy
AT ionelaelisabetastaicu bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy
AT gabrielsebastianpetrescu bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy
AT adelailaasan bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy
AT sandamihaelapopescu bisphosphonatesrelatedosteonecrosisofthejawincancerpatientsepidemiologicalstudy